Healthcare organizations seek solutions in national Measure Up, Pressure Down campaign

Article

Members of the American Medical Group Association (AMGA) are participating in Measure Up, Pressure Down, a nationwide healthcare initiative aimed at preventing, detecting, and controlling high blood pressure.

Alexandria, VA-More than 120 members of the American Medical Group Association (AMGA) have joined together to participate in Measure Up, Pressure Down, a new nationwide healthcare initiative aimed at preventing, detecting, and controlling high blood pressure.

Measure Up, Pressure Down is a 3-year campaign that targets having 80% of hypertensive patients in control of their condition by 2016. The program is spearheaded by the American Medical Group Foundation (AMGF), AMGA’s nonprofit education and research arm. Participating organizations include the U.S. Department of Health and Human Services, Mayo Clinic, Cleveland Clinic, Kaiser Permanente, and Geisinger Health System.

“By challenging medical groups and health providers to raise the bar on high blood pressure care and control, we can make a dramatic difference in the health and wellbeing of our population,” said Donald W. Fisher, PhD, CAE, president and chief executive officer of AMGA and secretary of the board of AMGF. “AMGA member medical groups are well positioned to successfully lead this critically important national effort.”

The campaign is sponsored by Novartis Pharmaceuticals Corp. and Daiichi Sankyo Inc. For more information, visit www.MeasureUpPressureDown.com.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.